Lv21
126 积分 2026-04-22 加入
Incidence, Characteristics, and Management of Venous Thrombosis in Adult Patients With Immune Thrombocytopenia: Results From the Multicenter, Prospective Registry CARMEN-France
4天前
已完结
Geographic and diagnostic variations in thrombosis risk among patients with immune thrombocytopenia: A systematic review and meta-analysis
4天前
已完结
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink
5天前
已完结
The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review
7天前
已完结
Daratumumab as a novel treatment option in refractory ITP
7天前
已完结
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
10天前
已完结
Ianalumab plus Eltrombopag in Immune Thrombocytopenia
10天前
已完结
Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial
10天前
已完结
Chronic myeloid leukaemia: Biology and therapy
13天前
已完结
The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
14天前
已完结
皖公网安备34019202002308
